Results show Moderna COVID-19 vaccine safe; phase 3 trials to start this month
New York: US-based pharmaceutical major Moderna's experimental vaccine, mRNA-1273, designed to protect against Covid-19 virus, was generally well tolerated and...
Moderna
COVID-19: Moderna vaccine shows early promise in human trial, stock soars
New York: In a ray of hope against Covid-19, an mRNA vaccine under human clinical trial by Massachusetts-bases biotechnology giant Moderna...
